Below is a list of ready-to-go slide decks that Chapter Leaders can use for their Spring or Fall Learning Series. Once a chapter has presented a slide deck, they may not present it again.
2025
Pulmonary Hypertension: From Examination to Management (1.0 CE contact hours)
Learning Objectives
- Examine assessment, diagnosis and staging of Pulmonary Hypertension (PH)
- Explain the risks of vascular and right ventricular remodeling when PH is under-treated or untreated
- Compare and contrast the mechanism of actions of traditional and novel therapies for PH management
- Explore the role of the CV RN in a team-based care approach to PH management
Lipid Management in 2025 (1.0 CE contact hours)
Learning Objectives
- Identify at risk populations with inherited and non-inherited hyperlipidemias highlighting testing guidelines
- Summarize pharmacologic and non-pharmacologic approaches to lowering lipids
- Using case studies, identify the appropriate lipid-lowering agent for specific patient scenarios
- Discuss solutions to close the gap across social determinants of health in application of evidence-based lipid lowering guideline
2024
Hypertrophic Cardiomyopathy: Advances in Disease Management (1.0 CE contact hours)
Learning Objectives
- Review signs and symptoms of HCM to aid earlier recognition
- Explain the differential diagnosis process to rule out non-HCM causes of left ventricular hypertrophy
- Explore the role of novel cardiac myosin inhibitor drug class on HCM treatment
- Examine best practices from a high volume HCM center in access and adherence to novel treatment
Nurse Leaders: Successful Strategies and Tip to Help Along the Way (0.5 CE – 1.0 CE contact hours)
Learning Objectives
- Describe varying leadership styles applicable to nursing
- Discuss application of leadership strategies in nursing
- Explore the benefits and responsibilities of being a mentor and a mentee
Cardiac Amyloidosis: Increasing Awareness and Understanding (1.0 CE contact hours)
Learning Objectives
- Review the prevalence and prognosis of risk for cardiac amyloidosis in heart failure patients emphasizing early diagnosis for improved outcomes
- Discuss the distribution of and inequities in diagnosis and care for cardiac amyloidosis across patient populations including race, ethnicity and gender
- Examine the evolving signs and symptoms of cardiac amyloidosis subtypes (hereditary and wild type) as seen in diagnostic imaging including evidence-based treatments for each
- Explore the role of cardiovascular nurse in cardiac amyloidosis treatment and management highlighting promotion of shared-decision making to empower patients to play an active role in their care
Nurse Health and Well-Being (1.0 CE contact hours)
Learning Objectives
- Identify the physical health concerns found to be prominent in the nursing population.
- Review the impact of burnout, current workforce issues and stress on the mental health of nurses.
- Discuss occupational health safety including variations and methods to leverage employer wellness programs and workplace environment issues to promote healthy lifestyles and health attainment by nurse employees.
- Explore best practices and innovation in self-care and health promotion of the nursing workforce.
2023
Maternal Mortality & Cardiovascular Disease (1.0 CE contact hours)
Learning Objectives
- Describe cardiovascular and cardiometabolic complications of pregnancy including long term risks across the lifespan.
- Discuss the impact of social determinants of heath and implicit bias on cardiovascular related maternal mortality.
- Review current women’s health guidelines, policies and recommendations.
- Discuss best practices to prevent maternal mortality including improved hypertension monitoring, increased access to perinatal appointments, and more.
A Heart Healthy Lifestyle Counseling: A Focus on the Female Patient (1.0 CE contact hours)
Learning Objectives
- Identify two pregnancy complications associated with future CVD risk.
- Describe the integration of brief dietary counseling into a clinical visit.
- Apply evidence-based interventions to promote physical activity and healthy eating including the PCNA Heart Healthy Toolbox.
Hypertension: Current Guideline Recommendations (1.0 CE contact hours)
Learning Objectives
- Review current hypertension guidelines.
- Describe the association between high blood pressure and cardiovascular disease risk.
- Explain the impact of implicit bias, oppression and discrimination on cardiovascular health.
- Discuss treatment strategies for hypertension according to patient’s risk level, co-morbidities, race/ethnicity age.
- National Guidelines for the Primary Prevention of CVD: Integrating Hypertension, Cholesterol, Diabetes, and Lifestyle
Guidelines into Practice (2.0 CE contact hours)
Learning Objectives
- Cite and locate national guidelines related to CVD Risk Reduction.
- Understand the class or strength of treatment recommendations in guidelines.
- Explain how CV risk assessment tools and patient-centered approaches can help to individualize comprehensive management of CV risk.
- Apply current CVD prevention and risk reduction guidelines to patient care planning for lifestyle, physical activity, obesity, and tobacco use using a case study approach
- Describe application of current guideline recommendations for diabetes, cholesterol, hypertension, aspirin use, and more.
AFib in Clinical Practice: Recommended Tools and Treatments to Prevent Stroke (1.0 CE contact hours)
Learning Objectives
- Discuss the risk factors associated with undiagnosed and asymptomatic atrial fibrillation.
- Incorporate effective strategies for early detection of AFib into clinical practice
- Select tools that can help in communicating risk factors, prevention strategies, and treatment approaches with patients.
- Identify key aspects of current recommendations on atrial fibrillation, anticoagulation, stroke risk, and prevention approaches.
2022
Beyond Glycemic Control with SGLT2s and GLP1s RAs: New Evidence of Improved Cardiac, Renal, and Obesity Outcomes for Patients With and Without Diabetes (1.0 CE contact hours, 1.0 Pharmacology)
Learning Objectives
- Explain the role, function, and side effects of SGLT2 inhibitors and GLP1 receptor agonists.
- Review the current evidence of the cardio-protective effects of SGLT2is and GLP1 RAs including positive outcomes in heart failure treatment and arrythmia reduction.
- Discuss the weight loss benefit evidence of GLP1 RAs and SGLT2is in the picture of diabetic and nondiabetic patients.
- Summarize the renal benefits evidence for patients with T2D prescribed SGLT2is or GLP1 RAs.
- Explore interventions and tools to increase access and adherence to medication using a case study approach.
ASCVD Risk Estimation and Communication (1.0 CE contact hours)
Learning Objectives
- Describe modifiable and non-modifiable risk factors and enhancers that are known to increase the risk of atherosclerotic cardiovascular disease (ASCVD).
- Explain currently available ASCVD risk estimation tools.
- Apply tools that can predict risk for ASCVD across patient populations using a case study approach.
- Summarize Coronary Artery Calcium Scoring considerations.
The Basics of 12 Lead ECG Interpretation (1.0 CE contact hours)
Learning Objectives
- Explain which wall of the heart is being affected by abnormalities seen in 12-lead ECGs.
- Identify which coronary artery is being affected based on 12-Lead ECG findings.
- Discuss patient care considerations of specific ECG findings including electrolyte imbalances, Takotsubo Cardiomyopathy, QT prolongation, ventricular hypertrophy, atrial enlargement and bundle branch blocks.
- Apply knowledge of 12-lead interpretation techniques.
2020
Recommending Exercise in those with Obesity and Cardiovascular Risk Factors (1.0 CE contact hours)
Learning Objectives
- Describe the risk factors for cardiovascular disease and their association with overweight and obesity.
- Explain the steps in performing a Cardiovascular (CV) risk assessment for exercise clearance.
- Discuss counseling strategies for prescribing safe and effective exercise.
2019
Peripheral Arterial Disease: Risk Factors, Screening & Treatment (1.0 CE)
Learning Objectives
- Outline the risk factors associated with PAD.
- Describe the clinical presentation of patients with PAD.
- List the steps to perform an Ankle Brachial Index (ABI) to screen for PAD.
- Discuss common treatments for PAD including a supervised exercise training (SET) program for patients with claudication.
2018
Screening for Non-Valvular Atrial Fibrillation: Identifying the Undiagnosed Patient (1.0 CE)
Learning Objectives
- Review prevalence and common risk factors associated with non-valvular atrial fibrillation (NVAF).
- Describe typical signs and symptoms of NVAF and how to assess for them during a clinical encounter.
- Discuss the importance of pulse taking and follow up ECG to screen high risk patients for NVAF.
- Using case examples, illustrate how to initiate NVAF treatment, provide follow-up and collaboration across the continuum of care to ensure optimal patient outcomes.
Women’s Cardiovascular Care Across the Life Course – Promoting Prevention Among Women Who Experience Adverse Pregnancy Outcomes (1.0 CE)
Learning Objectives
- Identify key adverse pregnancy outcomes (APOs) that are associated with future cardiovascular or cardiometabolic risk.
- Identify persons who are at increased risk for developing these pregnancy-related complications.
- Describe the cardiovascular or cardiometabolic risk associated with these pregnancy-related complications.
- Describe clinical guidelines and recommendations for postpartum follow up and risk reduction.
- Apply evidence-based interventions to promote healthy eating, physical activity, and breastfeeding during the postpartum and childbearing years.
Resource Details
Reviewed on
February 11, 2025
Related Resources

Patient Education Handouts
Understanding Your Risk for Heart Disease and Stroke Fact Sheet
February 12, 2024

